Print

Human Genome Sciences, Inc. (HGSI) Starts Shipping New Anthrax Drug  
2/2/2009 6:25:54 AM

WASHINGTON, Feb 2 (Reuters) - Human Genome Sciences Inc. said on Monday it was beginning delivery of 20,000 doses of ABthrax, which fights anthrax infection, to the U.S. government.
//-->